ArticleCentral-European journal of immunology2024
Predictive value of miR-582-5p for onset of sepsis-induced acute kidney injury and its functional role during disease development.
Article in Central-European journal of immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- MicroRNA-582-5p modulation of UBR5 affects inflammatory response and motor recovery after spinal cord injury.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p/HMGB2 axis.Journal of translational medicine · 2025Article
- Mechanistic clues from urinary trypsin inhibitor in sepsis research.Central-European journal of immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute kidney injury (AKI) is a common complication of sepsis, characterized by sharply declining renal function. As a global concern, understanding its pathogenesis and improving diagnosis and therapy face significant challenges. MicroRNAs are involved in the progression of a variety of diseases.This research was focused on differences in expression and clinical predictive value of miR-582-5p in sepsis-induced AKI. Material and methods: Blood and urine samples were collected from 180 patients. Sepsis-induced AKI was imitated in vitro by human kidney 2 (HK2) cells treated with 10 µg/ml lipopolysaccharide (LPS). The relative expression of miR-582-5p and HMGB2 in different conditions was quantified by qRT-PCR. Regulation of gene expression was performed by cell transfection. Cell viability and apoptosis were detected subsequently. Kidney injury and inflammatory assessment were analyzed by means of ELISA. Estimation of oxidative stress was performed using the corresponding kit. The dual luciferase reporter system verified the targeting relationship between miR-582-5p and HMGB2. Results: Relative expression of miR-582-5p was lower in sepsis patients who suffered AKI later, along with LPS-induced HK2 cells. Both weak viability and elevated apoptosis were reversed by up-regulated miR-582-5p in HK2 cells exposed to LPS. In addition, the concentration of inflammatory factors and oxidation levels showed a significant decrease, based on up-regulated miR-582-5p. The clinical predictive value of miR-582-5p was visualized by a ROC curve with high sensitivity and specificity. Conclusions: Up-regulated miR-582-5p reduced sepsis-induced AKI, and HMGB2 was a potential downstream target of miR-582-5p.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.